BMS-986489 (Atigotatug + Nivolumab) vs Durvalumab in Limited-stage Small-cell Lung Cancer (TIGOS-LS)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Melissa Johnson, MD
SCRI Development Innovations, LLC
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
33 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Southern Cancer Center
Daphne, Alabama, United States
Recruiting - Sansum Clinic
Santa Barbara, California, United States
Recruiting - Florida Cancer Specialists - South
Fort Myers, Florida, United States
Recruiting - University of Miami - Sylvester Cancer Center
Miami, Florida, United States
Active, not recruiting - Ocala Oncology Center
Ocala, Florida, United States
Recruiting - Florida Cancer Specialists - North
Orange City, Florida, United States
Recruiting - Cancer Care Centers of Brevard
Palm Bay, Florida, United States
Recruiting - Florida Cancer Specialists - East
West Palm Beach, Florida, United States
Recruiting - Piedmont Healthcare - Atlanta
Atlanta, Georgia, United States
Recruiting - Illinois Cancer Specialists
Arlington Heights, Illinois, United States
Recruiting - Illinois Cancer Care
Peoria, Illinois, United States
Recruiting - Indiana University Simon Cancer Center
Indianapolis, Indiana, United States
Recruiting - Baptist Health - Corbin
Corbin, Kentucky, United States
Recruiting - Baptist Health - Lexington
Lexington, Kentucky, United States
Recruiting - Baptist Health - Louisville
Louisville, Kentucky, United States
Recruiting - Minnesota Oncology Hematology
Maple Grove, Minnesota, United States
Recruiting - Missouri Cancer Associates
Columbia, Missouri, United States
Recruiting - White Plains Hospital Physician Associates
White Plains, New York, United States
Recruiting - Carolina Cancer Research Center
Wilson, North Carolina, United States
Recruiting - Oncology Hematology Care
Cincinnati, Ohio, United States
Recruiting - Mid Ohio Hem/ Onc Dba the Mark H Zangmeister Center
Columbus, Ohio, United States
Recruiting - Oncology Associates of Oregon (willamette Valley Cancer Institute and Research Center)
Eugene, Oregon, United States
Recruiting - Tennessee Cancer Specialists
Knoxville, Tennessee, United States
Recruiting - Scri Oncology Partners
Nashville, Tennessee, United States
Recruiting - Texas Oncology - West Texas
Amarillo, Texas, United States
Recruiting - Texas Oncology- Austin
Austin, Texas, United States
Recruiting - Texas Oncology - Gulf Coast
Beaumont, Texas, United States
Recruiting - Texas Oncology - Dfw
Dallas, Texas, United States
Recruiting - Texas Oncology - Northeast Texas
Denison, Texas, United States
Recruiting - Texas Oncology - San Antonio
San Antonio, Texas, United States
Recruiting - Virginia Cancer Specialists
Fairfax, Virginia, United States
Recruiting - Virginia Oncology Associates
Norfolk, Virginia, United States
Recruiting - Blue Ridge Cancer Center (oncology & Hematology Associates of Southwest Va)
Salem, Virginia, United States
Recruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 11 Mar 2025
- Primary completion
- 31 May 2032
- Completion
- 30 Sept 2032
- Last update posted
- 22 Apr 2026
- Registered enrollment
- 250
- Registry id
- NCT06773910
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.